[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Nonalcoholic Steatohepatitis (NASH) Market Report 2017

October 2017 | 107 pages | ID: U336BB1D3C9PEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Nonalcoholic Steatohepatitis (NASH) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Nonalcoholic Steatohepatitis (NASH) in these regions, from 2012 to 2022 (forecast).
United States Nonalcoholic Steatohepatitis (NASH) market competition by top manufacturers/players, with Nonalcoholic Steatohepatitis (NASH) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Boehringer Ingelheim
  • Cerenis Therapeutics
  • Connexios Life Sciences
  • Genfit
  • Islet Sciences
  • Nimbus Therapeutics
  • Verva Pharmaceuticals
  • Viking Therapeutics
  • Astazeneca Plc
  • Galmed Pharmaceuticals
  • GENFIT SA
  • Gilead Science
  • Novo Nordisk
  • Immuron
  • Intercepts Pharmaceuticals
  • Enzo Biochem
  • Tobira Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Weight Loss Treatment
  • Insulin-Sensitizing Agents
  • Lipid-Lowering Drugs
  • Antioxidants
  • Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Nonalcoholic Steatohepatitis (NASH) for each application, including
  • Hospitals
  • Clinics
  • Research Institute
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Nonalcoholic Steatohepatitis (NASH) Market Report 2017

1 NONALCOHOLIC STEATOHEPATITIS (NASH) OVERVIEW

1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH)
1.2 Classification of Nonalcoholic Steatohepatitis (NASH) by Product Category
  1.2.1 United States Nonalcoholic Steatohepatitis (NASH) Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Nonalcoholic Steatohepatitis (NASH) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Weight Loss Treatment
  1.2.4 Insulin-Sensitizing Agents
  1.2.5 Lipid-Lowering Drugs
  1.2.6 Antioxidants
  1.2.7 Other
1.3 United States Nonalcoholic Steatohepatitis (NASH) Market by Application/End Users
  1.3.1 United States Nonalcoholic Steatohepatitis (NASH) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Research Institute
  1.3.5 Other
1.4 United States Nonalcoholic Steatohepatitis (NASH) Market by Region
  1.4.1 United States Nonalcoholic Steatohepatitis (NASH) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2012-2022)
  1.4.3 Southwest Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2012-2022)
  1.4.5 New England Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2012-2022)
  1.4.6 The South Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2012-2022)
  1.4.7 The Midwest Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Nonalcoholic Steatohepatitis (NASH) (2012-2022)
  1.5.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2012-2022)
  1.5.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2012-2022)

2 UNITED STATES NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Nonalcoholic Steatohepatitis (NASH) Average Price by Players/Suppliers (2012-2017)
2.4 United States Nonalcoholic Steatohepatitis (NASH) Market Competitive Situation and Trends
  2.4.1 United States Nonalcoholic Steatohepatitis (NASH) Market Concentration Rate
  2.4.2 United States Nonalcoholic Steatohepatitis (NASH) Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Nonalcoholic Steatohepatitis (NASH) Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NONALCOHOLIC STEATOHEPATITIS (NASH) SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Region (2012-2017)
3.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Region (2012-2017)
3.3 United States Nonalcoholic Steatohepatitis (NASH) Price by Region (2012-2017)

4 UNITED STATES NONALCOHOLIC STEATOHEPATITIS (NASH) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2012-2017)
4.3 United States Nonalcoholic Steatohepatitis (NASH) Price by Type (2012-2017)
4.4 United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NONALCOHOLIC STEATOHEPATITIS (NASH) SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Application (2012-2017)
5.2 United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NONALCOHOLIC STEATOHEPATITIS (NASH) PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Boehringer Ingelheim
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Cerenis Therapeutics
  6.2.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Connexios Life Sciences
  6.3.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Genfit
  6.4.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Genfit Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Islet Sciences
  6.5.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Islet Sciences Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Nimbus Therapeutics
  6.6.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Verva Pharmaceuticals
  6.7.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Viking Therapeutics
  6.8.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Astazeneca Plc
  6.9.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Galmed Pharmaceuticals
  6.10.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 GENFIT SA
6.12 Gilead Science
6.13 Novo Nordisk
6.14 Immuron
6.15 Intercepts Pharmaceuticals
6.16 Enzo Biochem
6.17 Tobira Therapeutics

7 NONALCOHOLIC STEATOHEPATITIS (NASH) MANUFACTURING COST ANALYSIS

7.1 Nonalcoholic Steatohepatitis (NASH) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Nonalcoholic Steatohepatitis (NASH) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Forecast by Type (2017-2022)
11.3 United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Forecast by Application (2017-2022)
11.4 United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Nonalcoholic Steatohepatitis (NASH)
Figure United States Nonalcoholic Steatohepatitis (NASH) Market Size (K Pcs) by Type (2012-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type (Product Category) in 2016
Figure Weight Loss Treatment Product Picture
Figure Insulin-Sensitizing Agents Product Picture
Figure Lipid-Lowering Drugs Product Picture
Figure Antioxidants Product Picture
Figure Other Product Picture
Figure United States Nonalcoholic Steatohepatitis (NASH) Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Research Institute Examples
Table Key Downstream Customer in Research Institute
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD) by Region (2012-2022)
Figure The West Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nonalcoholic Steatohepatitis (NASH) Sales Share by Players/Suppliers
Figure 2017 United States Nonalcoholic Steatohepatitis (NASH) Sales Share by Players/Suppliers
Figure United States Nonalcoholic Steatohepatitis (NASH) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players/Suppliers
Figure 2017 United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players/Suppliers
Table United States Market Nonalcoholic Steatohepatitis (NASH) Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Nonalcoholic Steatohepatitis (NASH) Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Nonalcoholic Steatohepatitis (NASH) Market Share of Top 3 Players/Suppliers
Figure United States Nonalcoholic Steatohepatitis (NASH) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Nonalcoholic Steatohepatitis (NASH) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Nonalcoholic Steatohepatitis (NASH) Product Category
Table United States Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) by Region (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Share by Region (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Share by Region (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Region in 2016
Table United States Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Region (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Region (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Region in 2016
Table United States Nonalcoholic Steatohepatitis (NASH) Price (USD/Pcs) by Region (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) by Type (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Share by Type (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Share by Type (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Type in 2016
Table United States Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nonalcoholic Steatohepatitis (NASH) by Type (2012-2017)
Figure Revenue Market Share of Nonalcoholic Steatohepatitis (NASH) by Type in 2016
Table United States Nonalcoholic Steatohepatitis (NASH) Price (USD/Pcs) by Types (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Type (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) by Application (2012-2017)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application in 2016
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2012-2017)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in United States (2012-2017)
Table Cerenis Therapeutics Basic Information List
Table Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2012-2017)
Figure Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Market Share in United States (2012-2017)
Figure Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in United States (2012-2017)
Table Connexios Life Sciences Basic Information List
Table Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2012-2017)
Figure Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Sales Market Share in United States (2012-2017)
Figure Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in United States (2012-2017)
Table Genfit Basic Information List
Table Genfit Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genfit Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2012-2017)
Figure Genfit Nonalcoholic Steatohepatitis (NASH) Sales Market Share in United States (2012-2017)
Figure Genfit Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in United States (2012-2017)
Table Islet Sciences Basic Information List
Table Islet Sciences Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Islet Sciences Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2012-2017)
Figure Islet Sciences Nonalcoholic Steatohepatitis (NASH) Sales Market Share in United States (2012-2017)
Figure Islet Sciences Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in United States (2012-2017)
Table Nimbus Therapeutics Basic Information List
Table Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2012-2017)
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Market Share in United States (2012-2017)
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in United States (2012-2017)
Table Verva Pharmaceuticals Basic Information List
Table Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2012-2017)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales Market Share in United States (2012-2017)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in United States (2012-2017)
Table Viking Therapeutics Basic Information List
Table Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2012-2017)
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Market Share in United States (2012-2017)
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in United States (2012-2017)
Table Astazeneca Plc Basic Information List
Table Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2012-2017)
Figure Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales Market Share in United States (2012-2017)
Figure Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in United States (2012-2017)
Table Galmed Pharmaceuticals Basic Information List
Table Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2012-2017)
Figure Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales Market Share in United States (2012-2017)
Figure Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in United States (2012-2017)
Table GENFIT SA Basic Information List
Table Gilead Science Basic Information List
Table Novo Nordisk Basic Information List
Table Immuron Basic Information List
Table Intercepts Pharmaceuticals Basic Information List
Table Enzo Biochem Basic Information List
Table Tobira Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Steatohepatitis (NASH)
Figure Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)
Figure Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Players/Suppliers in 2016
Table Major Buyers of Nonalcoholic Steatohepatitis (NASH)
Table Distributors/Traders List
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories